Osman Yokus, Erdem Sunger, Tahir Alper Cinli, Hasan Goze, Istemi Serin
{"title":"Serum albumin and ferritin levels: a practical indicator of prognosis in acute myeloid leukemia over 50 years of age?","authors":"Osman Yokus, Erdem Sunger, Tahir Alper Cinli, Hasan Goze, Istemi Serin","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Low albumin and high ferritin levels have negative effects on survival in acute myeloid leukemia (AML). In this study, the aim is to determine the role of these factors on survival in patients over 50 years of age with AML.</p><p><strong>Methods: </strong>Eighty patients followed up between January 2014 and July 2019 were included in the study. Patients were categorised into three subgroups: The favorable, intermediate and high-risk groups.</p><p><strong>Results: </strong>The overall survival of the favorable group was found to be longer in a statistically significant way.</p><p><strong>Conclusion: </strong>In this study, it has been shown that serum albumin and ferritin values are useful and simple laboratory values to show prognosis in AML over 50 years of age.</p>","PeriodicalId":7479,"journal":{"name":"American journal of blood research","volume":"12 3","pages":"97-104"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301019/pdf/ajbr0012-0097.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of blood research","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Low albumin and high ferritin levels have negative effects on survival in acute myeloid leukemia (AML). In this study, the aim is to determine the role of these factors on survival in patients over 50 years of age with AML.
Methods: Eighty patients followed up between January 2014 and July 2019 were included in the study. Patients were categorised into three subgroups: The favorable, intermediate and high-risk groups.
Results: The overall survival of the favorable group was found to be longer in a statistically significant way.
Conclusion: In this study, it has been shown that serum albumin and ferritin values are useful and simple laboratory values to show prognosis in AML over 50 years of age.